📣 VC round data is live. Check it out!

Cachet Pharmaceuticals Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cachet Pharmaceuticals and similar public comparables like Farmacias Benavides, Genky Drug Stores, Zjamp Group, JZJ Chain Drugstore and more.

Cachet Pharmaceuticals Overview

About Cachet Pharmaceuticals

Cachet Pharmaceutical Co Ltd is a state-owned stock company. Its main business includes: Medicine supply to hospitals, wholesaling of biological products, medical instruments, and traditional Chinese medicines. The Company also involved in pharmaceutical logistics and retail pharmacy chain.


Founded

1997

HQ

China

Employees

N/A

Sectors

Financials (FY)

Revenue: $3B
EBITDA: $66M

EV

$484M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cachet Pharmaceuticals Financials

Cachet Pharmaceuticals reported last fiscal year revenue of $3B and EBITDA of $66M.

In the same fiscal year, Cachet Pharmaceuticals generated $183M in gross profit, $66M in EBITDA, and $16M in net income.


Cachet Pharmaceuticals P&L

In the most recent fiscal year, Cachet Pharmaceuticals reported revenue of $3B and EBITDA of $66M.

Cachet Pharmaceuticals is profitable as of last fiscal year, with gross margin of 6%, EBITDA margin of 2%, and net margin of 1%.

See analyst estimates for Cachet Pharmaceuticals
Last FY202320242025202620272028
Revenue$3B$4B$4B$3B
Gross Profit$183M$290M$232M$183M
Gross Margin6%7%7%6%
EBITDA$66M$135M$118M$66M
EBITDA Margin2%3%3%2%
EBIT Margin4%3%3%4%
Net Profit$16M$36M$23M$16M
Net Margin1%1%1%1%

Financial data powered by Morningstar, Inc.

Cachet Pharmaceuticals Stock Performance

Cachet Pharmaceuticals has current market cap of $590M, and enterprise value of $484M.

Market Cap Evolution


Cachet Pharmaceuticals' stock price is $2.02.

Cachet Pharmaceuticals share price increased by 0.1% in the last 30 days, and by 1.7% in the last year.

Cachet Pharmaceuticals has an EPS (earnings per share) of $0.06.

See more trading valuation data for Cachet Pharmaceuticals
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$484M$590M0.0%0.1%-12.0%1.7%$0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cachet Pharmaceuticals Valuation Multiples

Cachet Pharmaceuticals trades at 0.2x EV/Revenue multiple, and 7.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Cachet Pharmaceuticals

Cachet Pharmaceuticals Financial Valuation Multiples

As of May 4, 2026, Cachet Pharmaceuticals has market cap of $590M and EV of $484M.

Cachet Pharmaceuticals has a P/E ratio of 36.1x.

Last FY202320242025202620272028
EV/Revenue0.2x0.1x0.1x0.2x
EV/EBITDA7.4x3.6x4.1x7.4x
EV/EBIT4.6x3.6x4.8x4.6x
EV/Gross Profit2.6x1.7x2.1x2.6x
P/E36.1x16.3x25.5x36.1x
EV/FCF2.4x2.4x20.0x2.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cachet Pharmaceuticals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cachet Pharmaceuticals Margins & Growth Rates

In the most recent fiscal year, Cachet Pharmaceuticals reported gross margin of 6%, EBITDA margin of 2%, and net margin of 1%.

See estimated margins and future growth rates for Cachet Pharmaceuticals

Cachet Pharmaceuticals Margins

Last FY20242025202720282029
Gross Margin6%7%6%
EBITDA Margin2%3%2%
EBIT Margin4%3%4%
Net Margin1%1%1%
FCF Margin7%1%7%

Cachet Pharmaceuticals Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(20%)(19%)
Gross Profit Growth(20%)(21%)
EBITDA Growth(13%)(44%)
EBIT Growth(25%)5%
Net Profit Growth(36%)(30%)
FCF Growth(88%)730%

Data powered by FactSet, Inc. and Morningstar, Inc.

Cachet Pharmaceuticals Operational KPIs

Access forward-looking KPIs for Cachet Pharmaceuticals
Last FY202320242025202620272028
S&M Expenses to Revenue0%1%1%0%
G&A Expenses to Revenue0%0%1%0%
Opex to Revenue3%4%4%3%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cachet Pharmaceuticals Competitors

Cachet Pharmaceuticals competitors include Farmacias Benavides, Genky Drug Stores, Zjamp Group, JZJ Chain Drugstore, YSB, DocMorris, Cawachi, Dimed SA, Luyan Pharma and Shu Yu Civilian Pharmacy.

Most Cachet Pharmaceuticals public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Farmacias Benavides0.8x7.3x
Genky Drug Stores0.6x0.6x7.8x7.8x
Zjamp Group0.0x0.9x
JZJ Chain Drugstore0.8x5.9x
YSB0.1x5.6x
DocMorris0.4x0.4x(11.3x)(10.8x)
Cawachi0.2x0.2x4.0x
Dimed SA0.6x0.6x6.1x9.4x

This data is available for Pro users. Sign up to see all Cachet Pharmaceuticals competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cachet Pharmaceuticals

When was Cachet Pharmaceuticals founded?Cachet Pharmaceuticals was founded in 1997.
Where is Cachet Pharmaceuticals headquartered?Cachet Pharmaceuticals is headquartered in China.
Is Cachet Pharmaceuticals publicly listed?Yes, Cachet Pharmaceuticals is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Cachet Pharmaceuticals?Cachet Pharmaceuticals trades under 002462 ticker.
When did Cachet Pharmaceuticals go public?Cachet Pharmaceuticals went public in 2010.
Who are competitors of Cachet Pharmaceuticals?Cachet Pharmaceuticals main competitors include Farmacias Benavides, Genky Drug Stores, Zjamp Group, JZJ Chain Drugstore, YSB, DocMorris, Cawachi, Dimed SA, Luyan Pharma, Shu Yu Civilian Pharmacy.
What is the current market cap of Cachet Pharmaceuticals?Cachet Pharmaceuticals' current market cap is $590M.
What is the current revenue of Cachet Pharmaceuticals?Cachet Pharmaceuticals' last fiscal year revenue is $3B.
What is the current EV/Revenue multiple of Cachet Pharmaceuticals?Current revenue multiple of Cachet Pharmaceuticals is 0.2x.
Is Cachet Pharmaceuticals profitable?No, Cachet Pharmaceuticals is not profitable.
How many companies Cachet Pharmaceuticals has acquired to date?Cachet Pharmaceuticals hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cachet Pharmaceuticals has invested to date?Cachet Pharmaceuticals hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cachet Pharmaceuticals

Lists including Cachet Pharmaceuticals

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial